| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;93:1107-1113.)
© 1996 American Heart Association, Inc.
Articles |
From the Evans Memorial Department of Medicine and the Whitaker Cardiovascular Institute, Boston University Medical Center (G.N.L., B.F., S.N.K., J.F.K., J.A.V.), and the Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School (M.D.G.), Boston, Mass.
Background In the setting of atherosclerosis, endothelial vasomotor function is abnormal. Increased oxidative stress has been implicated as one potential mechanism for this observation. We therefore hypothesized that an antioxidant, ascorbic acid, would improve endothelium-dependent arterial dilation in patients with coronary artery disease.
Methods and Results Brachial artery endothelium-dependent dilation in response to hyperemia was assessed by high-resolution vascular ultrasound before and 2 hours after oral administration of either 2 g ascorbic acid or placebo in a total of 46 patients with documented coronary artery disease. Plasma ascorbic acid concentration increased 2.5-fold 2 hours after treatment (46±8 to 114±11 µmol/L, P=.001). In the prospectively defined group of patients with an abnormal baseline response (<5% dilation), ascorbic acid produced marked improvement in dilation (2.0±0.6% to 9.7±2.0%), whereas placebo had no effect (1.1±1.5% to 1.7±1.5%, P=.003 for ascorbic acid versus placebo). Ascorbic acid had no effect on hyperemic flow or arterial dilation to sublingual nitroglycerin.
Conclusions Ascorbic acid reverses endothelial vasomotor dysfunction in the brachial circulation of patients with coronary artery disease. These findings suggest that increased oxidative stress contributes to endothelial dysfunction in patients with atherosclerosis and that endothelial dysfunction may respond to antioxidant therapy.
Key Words: antioxidants endothelium coronary disease
This article has been cited by other articles:
![]() |
A. J. Donato, I. Eskurza, K. L. Jablonski, L. B. Gano, G. L. Pierce, and D. R. Seals Cytochrome P-450 2C9 signaling does not contribute to age-associated vascular endothelial dysfunction in humans J Appl Physiol, October 1, 2008; 105(4): 1359 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Romano, C. Briguori, C. Quintavalle, C. Zanca, N. V. Rivera, A. Colombo, and G. Condorelli Contrast agents and renal cell apoptosis Eur. Heart J., May 8, 2008; (2008) ehn197v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saglam, U. Bozlar, F. Kantarci, H. Ay, B. Battal, and U. Coskun Effect of Hyperbaric Oxygen on Flow-Mediated Vasodilation: An Ultrasound Study J. Ultrasound Med., February 1, 2008; 27(2): 209 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lavi, A. Prasad, E. H. Yang, V. Mathew, R. D. Simari, C. S. Rihal, L. O. Lerman, and A. Lerman Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease Circulation, May 22, 2007; 115(20): 2621 - 2627. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. McNulty, B. J. Robertson, M. A. Tulli, J. Hess, L. A. Harach, S. Scott, and L. I. Sinoway Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease J Appl Physiol, May 1, 2007; 102(5): 2040 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Landmesser, S. Spiekermann, C. Preuss, S. Sorrentino, D. Fischer, C. Manes, M. Mueller, and H. Drexler Angiotensin II Induces Endothelial Xanthine Oxidase Activation: Role for Endothelial Dysfunction in Patients With Coronary Disease Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 943 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S G. Wannamethee, G. D. Lowe, A. Rumley, K R. Bruckdorfer, and P. H Whincup Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis Am. J. Clinical Nutrition, March 1, 2006; 83(3): 567 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, R. J. Karne, G. Hall, U. Campia, J. A. Panza, R. O. Cannon III, Y. Wang, A. Katz, M. Levine, and M. J. Quon High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H137 - H145. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Sheng, D. Wang, and A. P. Braun DAF-FM (4-Amino-5-methylamino-2',7'-difluorofluorescein) Diacetate Detects Impairment of Agonist-Stimulated Nitric Oxide Synthesis by Elevated Glucose in Human Vascular Endothelial Cells: Reversal by Vitamin C and L-Sepiapterin J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 931 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Tousoulis, C Xenakis, C Tentolouris, G Davies, C Antoniades, T Crake, and C Stefanadis Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina Heart, October 1, 2005; 91(10): 1319 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Munzel, A. Daiber, V. Ullrich, and A. Mulsch Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1551 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Stone, D. M. Lloyd-Jones, S. Kinlay, B. Frei, W. Carlson, J. Rubenstein, T. C. Andrews, M. Johnstone, G. Sopko, H. Cole, et al. Effect of Intensive Lipid Lowering, With or Without Antioxidant Vitamins, Compared With Moderate Lipid Lowering on Myocardial Ischemia in Patients With Stable Coronary Artery Disease: The Vascular Basis for the Treatment of Myocardial Ischemia Study Circulation, April 12, 2005; 111(14): 1747 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Spargias, E. Alexopoulos, S. Kyrzopoulos, P. Iacovis, D. C. Greenwood, A. Manginas, V. Voudris, G. Pavlides, C. E. Buller, D. Kremastinos, et al. Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention Circulation, November 2, 2004; 110(18): 2837 - 2842. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Takase, H. Etsuda, Y. Matsushima, M. Ayaori, H. Kusano, A. Hamabe, A. Uehata, F. Ohsuzu, M. Ishihara, and A. Kurita Effect of Chronic Oral Supplementation with Vitamins on the Endothelial Function in Chronic Smokers Angiology, November 1, 2004; 55(6): 653 - 660. [Abstract] [PDF] |
||||
![]() |
R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Cohn, A. A. Quyyumi, N. K. Hollenberg, and K. A. Jamerson Surrogate Markers for Cardiovascular Disease: Functional Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-31 - IV-46. [Full Text] [PDF] |
||||
![]() |
S. Kawashima and M. Yokoyama Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 998 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vergely, F. Goirand, A. Ecarnot-Laubriet, C. Renard, D. Moreau, J.-C. Guilland, M. Dumas, and L. Rochette Vitamin C Deficiency Exerts Paradoxical Cardiovascular Effects in Osteogenic Disorder Shionogi (ODS) Rats J. Nutr., April 1, 2004; 134(4): 729 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Eskurza, K. D. Monahan, J. A. Robinson, and D. R. Seals Ascorbic acid does not affect large elastic artery compliance or central blood pressure in young and older men Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1528 - H1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Eskurza, K. D. Monahan, J. A. Robinson, and D. R. Seals Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing J. Physiol., April 1, 2004; 556(1): 315 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Alp and K. M. Channon Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 413 - 420. [Abstract] [Full Text] |
||||
![]() |
S. Fichtlscherer, S. Dimmeler, S. Breuer, R. Busse, A. M. Zeiher, and I. Fleming Inhibition of Cytochrome P450 2C9 Improves Endothelium-Dependent, Nitric Oxide-Mediated Vasodilatation in Patients With Coronary Artery Disease Circulation, January 20, 2004; 109(2): 178 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Madhavan and J. Goodfellow Lack of evidence for vitamin C as acute vasodilator J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1671 - 1672. [Full Text] [PDF] |
||||
![]() |
R. F. Redberg, R. A. Vogel, M. H. Criqui, D. M. Herrington, J. A. C. Lima, and M. J. Roman Task force #3--what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1886 - 1898. [Full Text] [PDF] |
||||
![]() |
G. D. Plotnick, M. C. Corretti, R. A. Vogel, R. Hesslink Jr, and J. A. Wise Effect of supplemental phytonutrients on impairment of the flow-mediated brachialartery vasoactivity after a single high-fat meal J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1744 - 1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gokce, J. F. Keaney Jr, L. M. Hunter, M. T. Watkins, Z. S. Nedeljkovic, J. O. Menzoian, and J. A. Vita Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1769 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Spiekermann, U. Landmesser, S. Dikalov, M. Bredt, G. Gamez, H. Tatge, N. Reepschlager, B. Hornig, H. Drexler, and D. G. Harrison Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease: Relation to Endothelium-Dependent Vasodilation Circulation, March 18, 2003; 107(10): 1383 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Anderson, J. Hubacek, D. G. Wyse, and M. L. Knudtson Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy J. Am. Coll. Cardiol., February 5, 2003; 41(3): 420 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Drossos, I. K. Toumpoulis, D. G. Katritsis, J. P. A. Ioannidis, P. Kontogiorgi, E. Svarna, and C. E. Anagnostopoulos Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 330 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Padayatty, A. Katz, Y. Wang, P. Eck, O. Kwon, J.-H. Lee, S. Chen, C. Corpe, A. Dutta, S. K Dutta, et al. Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention J. Am. Coll. Nutr., February 1, 2003; 22(1): 18 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. d'Uscio, S. Milstien, D. Richardson, L. Smith, and Z. S. Katusic Long-Term Vitamin C Treatment Increases Vascular Tetrahydrobiopterin Levels and Nitric Oxide Synthase Activity Circ. Res., January 10, 2003; 92(1): 88 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Fernandez-Real, G. Penarroja, A. Castro, F. Garcia-Bragado, A. Lopez-Bermejo, and W. Ricart Blood Letting in High-Ferritin Type 2 Diabetes: Effects on vascular reactivity Diabetes Care, December 1, 2002; 25(12): 2249 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes Endocr. Rev., October 1, 2002; 23(5): 599 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. McGrath, L. Dixon, D. R. Morgan, and G. E. McVeigh Production of 8-epi prostaglandin F2{alpha} in human platelets during administration of organic nitrates J. Am. Coll. Cardiol., August 21, 2002; 40(4): 820 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adachi, R. Matsui, S. Xu, M. Kirber, H. L. Lazar, V. S. Sharov, C. Schoneich, and R. A. Cohen Antioxidant Improves Smooth Muscle Sarco/Endoplasmic Reticulum Ca2+-ATPase Function and Lowers Tyrosine Nitration in Hypercholesterolemia and Improves Nitric Oxide-Induced Relaxation Circ. Res., May 31, 2002; 90(10): 1114 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Toth, Z. Kukor, and S. Valent Chemical stabilization of tetrahydrobiopterin by L-ascorbic acid: contribution to placental endothelial nitric oxide synthase activity Mol. Hum. Reprod., March 1, 2002; 8(3): 271 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Corretti, T. J. Anderson, E. J. Benjamin, D. Celermajer, F. Charbonneau, M. A. Creager, J. Deanfield, H. Drexler, M. Gerhard-Herman, D. Herrington, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force J. Am. Coll. Cardiol., January 16, 2002; 39(2): 257 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Maxwell, M. P. Zapien, G. L. Pearce, G. MacCallum, and P. H. Stone Randomized trial of a medical food for the dietary management of chronic, stable angina J. Am. Coll. Cardiol., January 2, 2002; 39(1): 37 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kelm Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H1 - H5. [Full Text] [PDF] |
||||
![]() |
U. Landmesser and D. G. Harrison Oxidant Stress as a Marker for Cardiovascular Events: Ox Marks the Spot Circulation, November 27, 2001; 104(22): 2638 - 2640. [Full Text] [PDF] |
||||
![]() |
T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, and T. Munzel Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease Circulation, November 27, 2001; 104(22): 2673 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takajo, H. Ikeda, N. Haramaki, T. Murohara, and T. Imaizumi Augmented oxidative stress of platelets in chronic smokers: Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1320 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Duffy, J. F. Keaney Jr, M. Holbrook, N. Gokce, P. L. Swerdloff, B. Frei, and J. A. Vita Short- and Long-Term Black Tea Consumption Reverses Endothelial Dysfunction in Patients With Coronary Artery Disease Circulation, July 10, 2001; 104(2): 151 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. A. Williams, W. H. F. Sutherland, M. P. McCormick, S. A. de Jong, J. R. McDonald, and R. J. Walker Vitamin C improves endothelial dysfunction in renal allograft recipients Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1251 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. A. Witte, A. L. Clark, and J. G. F. Cleland Chronic heart failure and micronutrients J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1765 - 1774. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Penny, O. Ben-Yehuda, K. Kuroe, J. Long, A. Bond, V. Bhargava, J. F. Peterson, M. McDaniel, J. Juliano, J. L. Witztum, et al. Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein J. Am. Coll. Cardiol., March 1, 2001; 37(3): 766 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hornig, U. Landmesser, C. Kohler, D. Ahlersmann, S. Spiekermann, A. Christoph, H. Tatge, and H. Drexler Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease : Role of Superoxide Dismutase Circulation, February 13, 2001; 103(6): 799 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mak and G. E. Newton Vitamin C Augments the Inotropic Response to Dobutamine in Humans With Normal Left Ventricular Function Circulation, February 13, 2001; 103(6): 826 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Duffy, N. Gokce, M. Holbrook, L. M. Hunter, E. S. Biegelsen, A. Huang, J. F. Keaney Jr., and J. A. Vita Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H528 - H534. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Block, A. R. Mangels, E. P. Norkus, B. H. Patterson, O. A. Levander, and P. R. Taylor Ascorbic Acid Status and Subsequent Diastolic and Systolic Blood Pressure Hypertension, February 1, 2001; 37(2): 261 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cai and D. G. Harrison Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress Circ. Res., November 10, 2000; 87(10): 840 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hirai, H. Kawano, O. Hirashima, T. Motoyama, Y. Moriyama, T. Sakamoto, K. Kugiyama, H. Ogawa, K. Nakao, and H. Yasue Insulin resistance and endothelial dysfunction in smokers: effects of vitamin C Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1172 - H1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.W. Laight, M.J. Carrier, and E.E. Anggard Antioxidants, diabetes and endothelial dysfunction Cardiovasc Res, August 18, 2000; 47(3): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Channon, H. Qian, and S. E. George Nitric Oxide Synthase in Atherosclerosis and Vascular Injury : Insights From Experimental Gene Therapy Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1873 - 1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lembo, C. Vecchione, R. Izzo, L. Fratta, D. Fontana, G. Marino, G. Pilato, and B. Trimarco Noradrenergic Vascular Hyper-Responsiveness in Human Hypertension Is Dependent on Oxygen Free Radical Impairment of Nitric Oxide Activity Circulation, August 1, 2000; 102(5): 552 - 557. [Abstract] [Full Text] [PDF] |
||||